Concepedia

Richard E. Valocik

RE

14

Publications

437

Citations

12

H-Index

1984

Active since

Affiliations

New Frontier(Current)

Upsher-Smith Laboratories (United Kingdom)

GlaxoSmithKline (United Kingdom)

GlaxoSmithKline (United States)

Richard E. Valocik is an author at New Frontier specializing in medicine, pharmacology, and pharmacotherapy.

Top concepts

Publications per year

1984–2008

14

Publications

14

Antithrombotic Efficacy of a Novel Murine Antihuman Factor IX Antibody in Rats

Giora Feuerstein, Arun Patel, John R. Toomey et al. · Arteriosclerosis Thrombosis and Vascular Biology · 1999 · 69 citations · Full text

, , +26

Effects of the leukotrienes on the vasculature and blood pressure of different species.

Barry A. Berkowitz, Bogdan Zabko-Potapovich, Richard E. Valocik et al. · Journal of Pharmacology and Experimental Therapeutics · 1984 · 63 citations

Inhibition of Factor IX(a) Is Protective in a Rat Model of Thromboembolic Stroke

John R. Toomey, Richard E. Valocik, Paul F. Koster et al. · Stroke · 2002 · 52 citations

An Inhibitory Anti-factor IX Antibody Effectively Reduces Thrombus Formation in a Rat Model of Venous Thrombosis

G Feuerstein, John R. Toomey, Richard E. Valocik et al. · Thrombosis and Haemostasis · 1999 · 51 citations

A comparison of the β‐D‐xyloside, odiparcil, to warfarin in a rat model of venous thrombosis

John R. Toomey, Melanie A Abboud, Richard E. Valocik et al. · Journal of Thrombosis and Haemostasis · 2006 · 36 citations · Full text

, , +9

Rows per page

1–5 of 14